# BioAxone Therapeutic

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/bioaxone-therapeutic

- Industry: Biotechnology
- Headquarters: Montreal, Canada
- Total disclosed funding: $29M
- Latest round: Series B (Dec 19, 2005)
- Investors on record: 5

## About

BioAxone Therapeutic, Inc. is based in Canada and operates as a neuroscience company. The company specializes in the development and commercialization of proprietary technologies that target Rho signaling.

## Funding rounds

- Series B, Dec 19, 2005, $5.1M — Fonds de Solidarité des Travailleurs du Québec, T2C2, Desjardins Capital, Lothian Partners
- Series B, May 23, 2005, $12M — Fonds de Solidarité des Travailleurs du Québec, T2C2, Desjardins Capital, Lothian Partners
- Series A, Jul 2, 2002, $12M — Fonds de Solidarité des Travailleurs du Québec, T2C2, Desjardins Capital, Innovatech Grand Montreal

## Investors

- Fonds de Solidarité des Travailleurs du Québec — Series A, Series B
- T2C2 (https://capitalatlas.ai/funds/t2c2) — Series A, Series B
- Desjardins Capital (https://capitalatlas.ai/funds/desjardins-capital) — Series A, Series B
- Innovatech Grand Montreal — Series A
- Lothian Partners — Series B